EDAP TMS S.A. American Depositary Shares (FOCL)
Summary
FocalTherics Q2 Earnings Call Highlights
FocalTherics NASDAQ: FOCL reported second-quarter HIFU revenue of $13.2 million, up 39% from $9.5 million a year earlier, as the company continued to expand sales of its Focal One high-intensity focused ultrasound platform for focal therapy.
FocalTherics (FOCL) Surges 6.2%: Is This an Indication of Further Gains?
FocalTherics (FOCL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
EDAP TMS S.A. American Depositary Shares Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 69,160 | $358,250 | $289,745.82 | -$68,504.18 | -19.12% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 50 | $98 | $206.75 | $108.75 | 110.97% |
 Robert Bruce Robert Jeffrey Bruce is VP/Secretary at Bruce & Co Inc. | 438,652 | $850,968.52 | $2.09M | $1.24M | 145.37% |
| EM Erin Mccann Simplicity Wealth LLC | 12,265 | $24,227.25 | $75,061.8 | $50,834.55 | 209.82% |
EDAP TMS S.A. American Depositary Shares (FOCL) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has EDAP TMS S.A. American Depositary Shares ever had a stock split?
EDAP TMS S.A. American Depositary Shares Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Ryan Rhodes CEO | NASDAQ (NMS) Exchange | 268311107 CUSIP |
| FR Country | 289 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
EDAP TMS SA is a holding company based in Vaulx-en-Velin, France, focused on the development, production, and marketing of cutting-edge, minimally invasive medical devices tailored for the treatment of urological diseases. Established on December 3, 1979, the company operates primarily through two segments: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). These segments work together to advance technologies in the medical field, providing innovative solutions for various urological conditions.
Products and Services
- High Intensity Focused Ultrasound (HIFU) Devices
This segment specializes in devices designed for the minimally invasive ablation of localized tumors. HIFU technology utilizes focused ultrasound waves to precisely target and destroy tumor tissue while preserving surrounding healthy organs, making it a preferred option for patients seeking effective, non-invasive treatments.
- Urology Devices
The Urology Devices and Services segment is dedicated to the creation, marketing, and servicing of medical devices aimed at the diagnosis and treatment of urological disorders. This includes the management of urinary stones and other clinical conditions, providing healthcare professionals with tools that enhance patient care and improve outcomes.
- Minimally Invasive Treatment Solutions
EDAP TMS SA focuses on offering surgical solutions that reduce patient recovery time and discomfort. By employing minimally invasive techniques, the company contributes to the modernization of urological procedures, enabling quicker and safer interventions for patients facing urological challenges.
- Comprehensive Patient Care Services
In addition to manufacturing devices, EDAP TMS SA engages in comprehensive service offerings, including maintenance and support for its product range. This commitment ensures that healthcare providers can rely on consistent and effective equipment performance to deliver optimal patient care.
